These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 1436393)
1. The effects of intravenous administration of cholecystokinin on feeding behaviour and release of pituitary hormones in pigs are not mediated by serotonergic (5-HT3) receptors. Parrott RF; Ebenezer IS; Forsling ML Neuropharmacology; 1992 Sep; 31(9):863-7. PubMed ID: 1436393 [TBL] [Abstract][Full Text] [Related]
2. CCK-A receptors mediate the effect of cholecystokinin on vasopressin but not on cortisol in pigs. Parrott RF; Forsling ML Am J Physiol; 1992 Jun; 262(6 Pt 2):R1154-7. PubMed ID: 1621871 [TBL] [Abstract][Full Text] [Related]
3. Central and peripheral doses of cholecystokinin that inhibit feeding in pigs also stimulate vasopressin and cortisol release. Parrott RF; Ebenezer IS; Baldwin BA; Forsling ML Exp Physiol; 1991 Jul; 76(4):525-31. PubMed ID: 1910760 [TBL] [Abstract][Full Text] [Related]
4. Hormonal effects of apomorphine and cholecystokinin in pigs: modification of the response to cholecystokinin by a dopamine antagonist (metoclopramide) and a kappa opioid agonist (PD117302). Parrott RF; Ebenezer IS; Baldwin BA; Forsling ML Acta Endocrinol (Copenh); 1991 Oct; 125(4):420-6. PubMed ID: 1957561 [TBL] [Abstract][Full Text] [Related]
5. Serotonin type-3 receptors mediate cholecystokinin-induced satiation through gastric distension. Hayes MR; Chory FM; Gallagher CA; Covasa M Am J Physiol Regul Integr Comp Physiol; 2006 Jul; 291(1):R115-23. PubMed ID: 16484443 [TBL] [Abstract][Full Text] [Related]
6. Dorsal hindbrain 5-HT3 receptors participate in control of meal size and mediate CCK-induced satiation. Hayes MR; Covasa M Brain Res; 2006 Aug; 1103(1):99-107. PubMed ID: 16793030 [TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors. Hayes MR; Savastano DM; Covasa M Physiol Behav; 2004 Sep; 82(4):663-9. PubMed ID: 15327914 [TBL] [Abstract][Full Text] [Related]
8. Ondansetron, a selective 5-HT3 receptor antagonist, reduces palatable food consumption in the nondeprived rat. van der Hoek GA; Cooper SJ Neuropharmacology; 1994 Jun; 33(6):805-11. PubMed ID: 7936118 [TBL] [Abstract][Full Text] [Related]
9. Acute and chronic role of 5-HT3 neuronal system on behavioral and neuroendocrine changes induced by intravenous cholecystokinin tetrapeptide administration in humans. Dépôt M; Caillé G; Mukherjee J; Katzman MA; Cadieux A; Bradwejn J Neuropsychopharmacology; 1999 Feb; 20(2):177-87. PubMed ID: 9885797 [TBL] [Abstract][Full Text] [Related]
10. Effects of the novel cholecystokinin analogue Suc-Trp-N(Me)-Nle-Asp-Phe-NH2 on feeding and cortisol release in pigs. Ebenezer IS; Parrott RF; Goode JA Pharmacol Biochem Behav; 1996 May; 54(1):255-9. PubMed ID: 8728566 [TBL] [Abstract][Full Text] [Related]
12. Gastric distension enhances CCK-induced Fos-like immunoreactivity in the dorsal hindbrain by activating 5-HT3 receptors. Hayes MR; Covasa M Brain Res; 2006 May; 1088(1):120-30. PubMed ID: 16630589 [TBL] [Abstract][Full Text] [Related]
13. CCK and 5-HT act synergistically to suppress food intake through simultaneous activation of CCK-1 and 5-HT3 receptors. Hayes MR; Covasa M Peptides; 2005 Nov; 26(11):2322-30. PubMed ID: 16269356 [TBL] [Abstract][Full Text] [Related]
14. Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers. Grady TA; Broocks A; Canter SK; Pigott TA; Dubbert B; Hill JL; Murphy DL Psychiatry Res; 1996 Aug; 64(1):1-10. PubMed ID: 8888359 [TBL] [Abstract][Full Text] [Related]
15. Ondansetron attenuates CCK induced satiety and c-fos labeling in the dorsal medulla. Daughters RS; Hofbauer RD; Grossman AW; Marshall AM; Brown EM; Hartman BK; Faris PL Peptides; 2001 Aug; 22(8):1331-8. PubMed ID: 11457529 [TBL] [Abstract][Full Text] [Related]
16. Investigation of the role of 5-HT3 receptors in the secretion of prolactin, ACTH and renin. Levy AD; Li Q; Rittenhouse PA; Van de Kar LD Neuroendocrinology; 1993 Jul; 58(1):65-70. PubMed ID: 8264857 [TBL] [Abstract][Full Text] [Related]
17. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats. Fekete M; Szabó A; Balázs M; Penke B; Telegdy G Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048 [TBL] [Abstract][Full Text] [Related]
18. Effects of food deprivation, strain, diet and age on feeding responses of fowls to intravenous injections of cholecystokinin. Savory CJ; Gentle MJ Appetite; 1983 Sep; 4(3):165-76. PubMed ID: 6667019 [TBL] [Abstract][Full Text] [Related]
19. Hypoglossal nerve response to 5-HT3 drugs injected into the XII nucleus and vena cava in the rat. Fenik P; Ogawa H; Veasey SC Sleep; 2001 Dec; 24(8):871-8. PubMed ID: 11766156 [TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin effects on feeding, glucose, and pancreatic hormones in rhesus monkeys. Metzger BL; Hansen BC Physiol Behav; 1983 Apr; 30(4):509-18. PubMed ID: 6348812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]